Pfizer Inc. closed out November trading with its best monthly advance in 30 years, as renewed virus fears revive the market’s focus on vaccine makers. The stock rose 2.5% to $53.73 in New York trading...
网页链接Pfizer Inc. closed out November trading with its best monthly advance in 30 years, as renewed virus fears revive the market’s focus on vaccine makers. The stock rose 2.5% to $53.73 in New York trading...
网页链接
精彩评论